Medical Device | December 22, 2025
Abbott wins FDA & CE nod for groundbreaking premature infant heart device
The system is intended for some of the tiniest patients—premature infants weighing as little as two pounds
The system is intended for some of the tiniest patients—premature infants weighing as little as two pounds
If approved, CUTX-101 will be the first and only FDA approved treatment available for Menkes disease
Qfitlia is the first antithrombin (AT)-lowering therapy approved for routine prophylaxis in hemophilia
Acetaminophen Injection is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older
It's a development that marks a potential breakthrough for people living with the rare and debilitating disease Duchenne muscular dystrophy (DMD)
The EMBOLD study evaluated relutrigine for patients with SCN2A and SCN8A developmental and epileptic encephalopathies
Seeing well-controlled Phase 3 data that shows a marked slowing of lesion growth in Stargardt disease is deeply encouraging
The study, which enrolled 35 Japanese patients, evaluated the percent change from baseline in the 24-hour urine protein-to-creatinine ratio
The fresh capital will propel Cordance into its first-in-human clinical trial
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
Subscribe To Our Newsletter & Stay Updated
